SCHEMBL18015387

SCHEMBL18015387

Clc1ccc(-c2ccc(-c3nc(C4CCCCC4)nc(C4CCCCC4)n3)cn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
CNR2 P34972 1/20 0.44
KDM1A O60341 1/20 0.43
MAOB P27338 1/20 0.43
ADORA3 P0DMS8 1/20 0.41
ADORA1 P30542 1/20 0.41
ALDH1A1 P00352 2/20 0.40
ALOX15B O15296 1/20 0.40
PDE4B Q07343 3/20 0.39
PDE4D Q08499 3/20 0.39
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
MCHR1 Q99705 1/20 0.36
HPGD P15428 1/20 0.36
CNR1 P21554 2/20 0.36
PSD A5PKW4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015633 0.91 ADORA1 (0.50) SMN1; SMN2NPC1RAB9ACNR2KDM1A
SCHEMBL19794496 0.82 ADORA1 (0.40) CNR2ADORA3ADORA1ALDH1A1PTPN2
SCHEMBL21202992 0.78 POLB (0.42) ADORA3ADORA1ALDH1A1MAPTHPGD
SCHEMBL18015316 0.77 DGAT1 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1PTPN2
SCHEMBL17486326 0.76 KDM4E (0.31) NPC1RAB9AALDH1A1PTPN2PTPN1
SCHEMBL17486335 0.76 RARA (0.33) NPC1RAB9AALDH1A1PTPN2PTPN1
SCHEMBL18015714 0.76 ADORA1 (0.43) ADORA3ADORA1ALDH1A1MAPTHPGD
SCHEMBL17486342 0.76 NPC1 (0.33) SMN1; SMN2NPC1RAB9AALDH1A1PTPN2
SCHEMBL17486241 0.75 MRGPRX2 (0.31)
SCHEMBL21203007 0.74 DGAT1 (0.36) PTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC SMN1; SMN2 4799/4885NPC1 4039/4885RAB9A 2171/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 SMN1; SMN2 4144/4885NPC1 2761/4885RAB9A 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.